SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-094900
Filing Date
2011-11-03
Accepted
2011-11-03 16:58:25
Documents
15
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b87804e10vq.htm 10-Q 551409
2 EX-10.1 b87804exv10w1.htm EX-10.1 83775
3 EX-12 b87804exv12.htm EX-12 19411
4 EX-31.1 b87804exv31w1.htm EX-31.1 8532
5 EX-31.2 b87804exv31w2.htm EX-31.2 8571
6 EX-32.1 b87804exv32w1.htm EX-32.1 3348
7 EX-32.2 b87804exv32w2.htm EX-32.2 3399
13 GRAPHIC b87804b8780401.gif GRAPHIC 2798
14 GRAPHIC b87804b8780402.gif GRAPHIC 6305
15 GRAPHIC b87804b8780403.gif GRAPHIC 5334
  Complete submission text file 0000950123-11-094900.txt   1935494

Data Files

Seq Description Document Type Size
8 EX-101 INSTANCE DOCUMENT alny-20110930.xml EX-101.INS 200909
9 EX-101 SCHEMA DOCUMENT alny-20110930.xsd EX-101.SCH 8018
10 EX-101 CALCULATION LINKBASE DOCUMENT alny-20110930_cal.xml EX-101.CAL 32622
11 EX-101 LABELS LINKBASE DOCUMENT alny-20110930_lab.xml EX-101.LAB 101474
12 EX-101 PRESENTATION LINKBASE DOCUMENT alny-20110930_pre.xml EX-101.PRE 64670
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 111178362
SIC: 2834 Pharmaceutical Preparations